Contracts › 75A50122C00008
75A50122C00008: High Throughput Sars-Cov-2 Neutralizing Antibody Immunoassay for Qualifying Variants and Testing of Human Serum Samples.
Awarded to Monogram Biosciences, Inc. by Office of Assistant Secretary for Preparedness and Response.
$38.0Mobligated
$38.0Mpotential value
30 September 2029current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50122C00008 |
|---|---|
| Awardee | Monogram Biosciences, Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | CA |
| Offers received | 1 |
| Period of performance | 29 November 2021 to 30 September 2029 |
| Potential end | 30 September 2029 |
| Estimated recompete solicitation | ~Q2 2029 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record